{"id":88066,"date":"2025-09-25T22:16:40","date_gmt":"2025-09-25T20:16:40","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=88066"},"modified":"2026-03-24T17:09:37","modified_gmt":"2026-03-24T16:09:37","slug":"safety-newsletter","status":"publish","type":"page","link":"https:\/\/www.veeva.com\/eu\/products\/safety-newsletter\/","title":{"rendered":"Veeva Safety Newsletter"},"content":{"rendered":"<style>\n.veeva-2024 #hero.hero-centered--image {\n--mobile-image: url(\/wp-content\/themes\/veeva2015\/assets\/veeva-2024\/background\/gateway-hero-mobile.jpg);\n--desktop-image: url(\/wp-content\/themes\/veeva2015\/assets\/veeva-2024\/background\/gateway-hero-desktop.jpg);\n}\n@media (min-width:768px) {\n.veeva-2024 .hero-centered {\npadding: 90px 0;\n}\n}<\/p>\n<p>.veeva-2024 .listed-up-card {\nbackground: white;\n}\n@media (min-width:992px) {\n.veeva-2024 .listed-up .copy-container {\nmargin-bottom: 60px;\n}\n}<\/p>\n<p>.veeva-2024 .floating-icon {\nposition:absolute;\nbottom:0;\nmargin-bottom: 25px;\n}<\/p>\n<p>.veeva-2024 .listed-up-card p {\npadding-bottom: 20px;\n}\n.veeva-2024 .listed-up-card .h5, .veeva-2024 .listed-up-card h5 {\nfont-size: 20px;\n}\n@media (min-width:768px) {\n.veeva-2024 .listed-up-card .h5, .veeva-2024 .listed-up-card h5 {\nfont-size: 22px;\n}\n}<\/p>\n<p>.mod-close .glyphicon {\ntop: 10px;\nright: 10px;\n}<\/p>\n<p>.form-shadow {\nbackground-color: #fff!important;\nborder: 1px solid #eee!important;\nbox-shadow: 1px 1px 11px #888!important;\npadding: 20px!important;\nborder-radius:16px!important;\n}<\/p>\n<p>.veeva-2024 .modal-btn-close {\nfloat: right;\nmargin-bottom: 10px;\n}\n<\/style>\n<p><main class=\"veeva-2024\"><\/p>\n<div style=\"background: #eef1f5;\">\n<section id=\"hero\" class=\"hero-centered hero-centered--image\">\n<div class=\"container copy-container copy-container--center\">\n<h6>Veeva Safety Newsletter<\/h6>\n<h1>Safety Innovation and<br \/> Industry News<\/h1>\n<p>Highlighting key industry insights, technology innovation,<br \/> and biopharmas advancing safety.\n\t\t<\/p>\n<div class=\"copy-container__buttons\">\n\t\t\t<a class=\"button-primary button-primary--gradient\" href=\"https:\/\/explore.veeva.com\/Veeva-Safety-Newsletter-LP-4470.html\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n\t\t\t\tSubscribe Now<br \/>\n\t\t\t<\/a>\n\t<\/div>\n<\/section>\n<p><!-- Listed up - Accent, Light, Icon --><\/p>\n<section class=\"listed-up listed-up-accent listed-up--light\" style=\"margin-top:90px;\">\n<div class=\"copy-container container copy-container--center copy-container--eyebrow-gradient\">\n<h3>Newsletters<\/h3>\n<\/p><\/div>\n<div class=\"listed-up__cards container\">\n<p>         <a class=\"listed-up-card listed-up-card-icon\" href=\"\/eu\/blog\/simplify-pva-management-and-improve-inspection-readiness\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 2, Edition 2<\/h4>\n<h5>Simplify PVA Management and Improve Inspection Readiness<\/h5>\n<p>Simplify oversight and collaboration of pharmacovigilance agreements (PVAs) and safety data exchange agreements (SDEAs) across partners to improve operational efficiency and inspection readiness.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><\/p>\n<p>         <a class=\"listed-up-card listed-up-card-icon\" href=\"\/eu\/blog\/unlocking-the-strategic-value-of-safety-data\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 2, Edition 1<\/h4>\n<h5>Unlocking the Strategic Value of Safety Data<\/h5>\n<p>Learn how safety teams are harnessing AI, automation, and real-time oversight to deliver increased efficiency and unlock the strategic value of safety data.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><\/p>\n<p>         <a class=\"listed-up-card listed-up-card-icon\" href=\"\/eu\/blog\/connected-systems-fastest-path-to-an-inspection-ready-psmf\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 8<\/h4>\n<h5>Connected Systems: Fastest Path to an Inspection-Ready PSMF<\/h5>\n<p>Explore how pharmacovigilance (PV) teams can use connected regulatory and safety systems to reduce manual updates and increase PSMF accuracy.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><\/p>\n<p>       <a class=\"listed-up-card listed-up-card-icon\" href=\"\/eu\/blog\/faster-and-easier-literature-review-to-case-intake\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 7<\/h4>\n<h5>Faster and Easier Literature Review to Case Intake<\/h5>\n<p>Literature review is a significant source of individual safety case reports (ICSRs). Learn how automation and an integrated safety system greatly reduces manual effort, as well as compliance and patient safety risks.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><\/p>\n<p>       <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/get-ready-for-fda-e2br3-what-pv-teams-need-to-know\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 6<\/h4>\n<h5>Get Ready for FDA E2B(R3): What PV Teams Need to Know<\/h5>\n<p>Understand FDA E2B(R3) reporting requirement for serious and unexpected suspected adverse reactions (SUSARs) and what PV teams need to do to prepare for the upcoming deadline.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><br \/>\n        <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/automate-safety-letter-distribution-80-faster-and-50-less-effort\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 5<\/h4>\n<h5>Automate Safety Letter Distribution: 80% Faster and 50% Less Effort<\/h5>\n<p>How safety letter distribution automates delivery of critical safety information to investigators and regulators with speed, efficiency, and quality.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><br \/>\n         <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/reduce-reconciliation-of-clinical-serious-adverse-events-sae\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 4<\/h4>\n<h5>Reduce Reconciliation of Clinical Serious Adverse Events (SAE)<\/h5>\n<p>Spotlight on the Safety-EDC Connection and how it automates the flow of serious adverse event (SAEs) records from data management teams to the safety inbox and reduces reconciliation.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><br \/>\n        <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/bring-safety-in-house-for-better-oversight-simplified-operational-reporting-and-cro-flexibility\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 3<\/h4>\n<h5>Bring Safety In-house for Better Oversight, Simplified Operational Reporting, and CRO Flexibility<\/h5>\n<p>How to achieve greater CRO collaboration and better pharmacovigilance (PV) oversight with easier operational reporting.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><br \/>\n        <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/reduce-case-rework-and-increase-data-quality-by-improving-case-processing-workflow\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 2<\/h4>\n<h5>Reduce Case Rework and Increase Data Quality by Improving Case Processing Workflow<\/h5>\n<p>The importance of quality control (QC) checklists in an end-to-end case processing workflow.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><br \/>\n        <a class=\"listed-up-card listed-up-card-icon\" href=\"https:\/\/www.veeva.com\/eu\/blog\/growing-risk-management-findings-how-to-get-ahead-and-improve-compliance\/\" target=\"_self\" rel=\"noopener\"><\/p>\n<h4>Volume 1, Edition 1<\/h4>\n<h5>Growing Risk Management Findings: How to Get Ahead and Improve Compliance<\/h5>\n<p>Learn why risk management is a top source of safety inspection findings and how to enhance your approach to global risk management.<\/p>\n<div class=\"floating-icon arrow-wrapper\">\n                <span class=\"icon\" data-icon=\"arrow-up-right--black\"><\/span>\n            <\/div>\n<p>        <\/a><\/p><\/div>\n<\/section>\n<section class=\"hero-contained hero-contained--gradient hero-contained--footer-fix\" style=\"--footer-fix-color: transparent; --footer-fix-color-desktop: transparent;\">\n<div class=\"container copy-container copy-container--center \">\n<h2>Veeva Safety Newsletter<\/h2>\n<div class=\"copy-container__buttons\">\n\t\t\t<a class=\"button-primary button-primary--gradient\" href=\"https:\/\/explore.veeva.com\/Veeva-Safety-Newsletter-LP-4470.html\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n\t\t\t\tSubscribe Now<br \/>\n\t\t\t<\/a>\n\t\t<\/div>\n<\/p><\/div>\n<\/section><\/div>\n<p><\/main><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Highlighting key industry insights, technology innovation, and biopharmas advancing safety.<\/p>\n","protected":false},"author":42,"featured_media":0,"parent":9525,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/veeva-2024.full-page.php","meta":{"footnotes":""},"coauthors":[],"class_list":["post-88066","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/88066"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/comments?post=88066"}],"version-history":[{"count":12,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/88066\/revisions"}],"predecessor-version":[{"id":95563,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/88066\/revisions\/95563"}],"up":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/9525"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=88066"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/coauthors?post=88066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}